From personal tragedy to personal challenge: responses to stigma among sober living home residents and operators
From personal tragedy to personal challenge: responses to stigma among sober living home residents and operators
复制标题
DOI：
10.1111/j.1467-9566.2011.01376.x
复制
发表时间：
2012-03-01
影响因子：
2.9
通讯作者：
Hamilton, Alison
中科院分区：
文献类型：
--
作者：
Heslin, Kevin C.;Singzon, Trudy;Hamilton, Alison
为那些试图戒除酒精和毒品的人提供的清醒生活之家，可以缓冲许多城市环境中普遍存在的高药物滥用率。清醒生活之家和其他残疾人团体之家一直面临着社区协会的持续反对，这引发了污名化的问题。这篇文章描述了清醒生活的家庭居民和经营者的反应，在不同的社区的耻辱的威胁。2009年1月至2010年3月期间，加州洛杉矶县共有68名居民和35家清醒生活之家的经营者参与了10个焦点小组的调查。结果表明，很少有居民报告邻居公然侮辱的经历；然而，他们很清楚人们可能把这些成见归到他们身上。尽管有这种潜在的耻辱，居民们还是在社区中建立了有价值的帮助者身份，为家人或朋友有药物使用问题的邻居提供建议，并组织社区服务活动来改善社区的面貌。随着他们对当地环境的关注，清醒生活之家的居民和经营者挑战了许多传统倡导与健康有关的耻辱的个人悲剧方法。
Sober living homes for people attempting to maintain abstinence from alcohol and drugs can act as a buffer against the high rates of substance misuse that are endemic to many urban environments. Sober living homes and other group homes for people with disabilities have faced persistent opposition from neighbourhood associations, which raises the question of stigma. This article describes the responses of sober living home residents and operators to the threat of stigma across a diverse set of neighbourhoods. Ten focus groups were conducted with 68 residents and operators of 35 sober living homes in Los Angeles County, California, between January 2009 and March 2010. Results showed that few residents reported experiences of blatant stigmatisation by neighbours; however, they were well aware of the stereotypes that could be ascribed to them. Despite this potential stigma, residents developed valued identities as helpers in their communities, providing advice to neighbours whose family or friends had substance use problems, and organising community service activities to improve the appearance of their neighbourhoods. With their attention to local context, sober living home residents and operators challenge the personal tragedy approach of much traditional advocacy on health-related stigma.